We are live on ! Find out more
EHI

Eagle Health Investments Portfolio holdings

AUM $603M
1-Year Est. Return 111.06%
This Fund
S&P 500
This Quarter Est. Return
-0.14%
1 Year Est. Return
+111.06%
3 Year Est. Return
+240.87%
5 Year Est. Return
+290.92%
10 Year Est. Return
–
AUM
$315M
AUM Growth
+$23.8M
Cap. Flow
+$26.7M
Cap. Flow %
8.48%
Top 10 Hldgs %
61.35%
Holding
29
New
–
Increased
13
Reduced
6
Closed
2

Top Buys

Rank Stock Value
1
HUM icon
Humana
HUM
+$8.83M
2
GH icon
Guardant Health
GH
+$8.01M
3
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
+$6.78M
4
OM icon
Outset Medical
OM
+$6.67M
5
ADPT icon
Adaptive Biotechnologies
ADPT
+$6.64M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$7.93M
2
PRVA icon
Privia Health
PRVA
+$4.26M
3
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$3.39M
4
AXNX
Axonics, Inc. Common Stock
AXNX
+$3.02M
5
SEER icon
Seer Inc
SEER
+$2.74M

Sector Composition

Rank Sector Weight
1 Healthcare 97.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AZN icon
1
AstraZeneca
AZN
$251B
$27M 8.56%
224,783
+24,888
+12% +$2.9M
HUM icon
2
Humana
HUM
$46.2B
$26.7M 8.46%
68,521
+20,800
+44% +$8.83M
IQV icon
3
IQVIA
IQV
$40B
$19.4M 6.17%
81,177
-4,100
-5% -$1.03M
NTRA icon
4
Natera
NTRA
$46.4B
$18.3M 5.81%
164,494
+1,300
+0.8% +$149K
BPMC
5
DELISTED
Blueprint Medicines
BPMC
$18.1M 5.74%
176,175
+35,412
+25% +$3.3M
UTHR icon
6
United Therapeutics
UTHR
$22.7B
$18.1M 5.74%
98,038
– –
ALNY icon
7
Alnylam Pharmaceuticals
ALNY
$29B
$17M 5.4%
90,102
-18,077
-17% -$3.39M
OM icon
8
Outset Medical
OM
$94M
$16.5M 5.22%
22,187
+9,787
+79% +$6.67M
ARGX icon
9
argenx
ARGX
$54.2B
$16.2M 5.14%
53,632
+400
+0.8% +$127K
DXCM icon
10
DexCom
DXCM
$33.2B
$16.1M 5.12%
118,000
-18,800
-14% -$2.37M
INSP icon
11
Inspire Medical Systems
INSP
$1.73B
$16M 5.07%
68,653
+12,600
+22% +$2.63M
ADPT icon
12
Adaptive Biotechnologies
ADPT
$4.09B
$15M 4.76%
441,466
+183,639
+71% +$6.64M
AXNX
13
DELISTED
Axonics, Inc. Common Stock
AXNX
$12.4M 3.93%
190,365
-44,200
-19% -$3.02M
GH icon
14
Guardant Health
GH
$22.8B
$12M 3.79%
95,660
+67,400
+238% +$8.01M
AGIO icon
15
Agios Pharmaceuticals
AGIO
$1.94B
$10.9M 3.45%
235,513
– –
MRTX
16
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$9.2M 2.92%
52,000
-5,900
-10% -$949K
CANO
17
DELISTED
Cano Health, Inc.
CANO
$8.58M 2.72%
6,764
+1,803
+36% +$2.18M
AMWL icon
18
American Well
AMWL
$232M
$8.21M 2.6%
45,065
+8,685
+24% +$1.88M
DRNA
19
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$8.2M 2.6%
406,525
+245,400
+152% +$6.78M
CMAX
20
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$5.96M 1.89%
20,559
+7,966
+63% +$2.34M
VRTX icon
21
Vertex Pharmaceuticals
VRTX
$132B
$5.36M 1.7%
29,544
-40,600
-58% -$7.93M
KYMR icon
22
Kymera Therapeutics
KYMR
$9.01B
$2.17M 0.69%
37,000
– –
CCCC icon
23
C4 Therapeutics
CCCC
$404M
$2.11M 0.67%
47,200
– –
ARVN icon
24
Arvinas
ARVN
$585M
$1.89M 0.6%
23,000
– –
FDMT icon
25
4D Molecular Therapeutics
FDMT
$572M
$1.54M 0.49%
57,090
– –
1
2

Similar funds

PIFP
Partners in Financial Planning Salem, Virginia $603M AUM 12.72% 1-Year Est. Return
IECM
Intrinsic Edge Capital Management Chicago, Illinois $603M AUM 66.97% 1-Year Est. Return
ERWM
Elk River Wealth Management Denver, Colorado $602M AUM 22.77% 1-Year Est. Return
CIG
Capricorn Investment Group Palo Alto, California $602M AUM 165.22% 1-Year Est. Return
JHCP
Jackson Hole Capital Partners Tulsa, Oklahoma $605M AUM 22.77% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
OCAM
Onex Canada Asset Management Toronto, Ontario, Canada $601M AUM 15.16% 1-Year Est. Return

Eagle Health Investments's Q3 2021 Portfolio in Review

As of Q3 2021, Eagle Health Investments held 29 positions worth $315M, up 8.2% from $291M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Eagle Health Investments deployed $26.7M of net new capital in Q3 2021, adding to 13 existing holdings.

By sector, the portfolio is most concentrated in Healthcare at 97% of assets, down from 98% a quarter earlier.

On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $7.93M trimmed.

  • Eagle Health Investments added most to Humana in Q3 2021, an estimated $8.83M increase.
  • Eagle Health Investments's biggest Q3 2021 reduction was Vertex Pharmaceuticals, cutting an estimated $7.93M.
  • Eagle Health Investments fully exited Privia Health in Q3 2021, selling an estimated $4.26M.
  • Eagle Health Investments's ten largest holdings make up 61% of its $315M portfolio in Q3 2021.
  • Eagle Health Investments opened 0 new positions and closed 2 in Q3 2021.
  • Eagle Health Investments's portfolio value rose 8.2% quarter-over-quarter to $315M.

Based on Eagle Health Investments's 13F filing for Q3 2021, filed 20 Oct 2021.